This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Seb Caille, PhD
Senior Director at Avidity Biosciences
Speaker

Profile

Seb Caille is a Senior Director at Avidity Biosciences, where he leads the Oligonucleotide Process Development team. Seb graduated with his Ph.D. in organic chemistry from the University of British Columbia, and, after a postdoctoral fellowship at UC Irvine, started his career at Amgen in the Synthetics Drug Substance Team. Seb has led teams performing route selection, process development, process characterization, and process validation activities for a diverse set of drug substance targets, including small molecules, oligonucleotides, glycosides, peptides, and bioconjugates. He is the author of forty-seven refereed publications throughout his career and the recipient of an EPA Green Chemistry Challenge Award (Sotorasib – 2022) and ACS Mid-Career Investigator Award (2024). He co-leads the Homogeneity Testing working group of IQ Consortium.

Agenda Sessions

  • Delivering on the RNA Revolution

    10:45